[THERAPEUTIC TRIAL OF A NEW BUFFER AGENT (THAM) IN METABOLIC ACIDOSIS OF RENAL ORIGIN].
D000138:Acidosis; D058186:Acute Kidney Injury; D000641:Ammonia; D001774:Blood Chemical Analysis; D002021:Buffers; D006947:Hyperkalemia; D007003:Hypoglycemia; D007010:Hyponatremia; D007223:Infant; D007474:Ion Exchange; D007668:Kidney; D007677:Kidney Function Tests; D011409:Propylene Glycols; D051437:Renal Insufficiency; D014116:Toxicology; D014325:Tromethamine; D014556:Urine; D014882:Water-Electrolyte Balance
D002021:Buffers; D011409:Propylene Glycols; D014325:Tromethamine; D000641:Ammonia
ACIDOSIS; AMMONIA; BLOOD CHEMICAL ANALYSIS; HYPERKALEMIA; HYPOGLYCEMIA; HYPONATREMIA; INFANT; ION EXCHANGE; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; PROPANEDIOLS; TOXICOLOGIC REPORT; TROMETHAMINE; URINE; WATER-ELECTROLYTE BALANCE
ENSAYO TERAP'EUTICO DE UN NUEVO AGENTE AMORTIGUADOR (THAM) EN ACIDOSIS METAB'OLICA DE ORIGEN RENAL.